While just 2 per cent of swine flu (H1N1) strains around the world are resistant to Tamiflu, the Australian research found mutations in all strains of the swine flu that suggest they might be prone to develop resistance.
Researchers found that one in five cases of swine flu in one area of Australia in 2011 were resistant to the antiviral medicine.
Dr Aeron Hurt from the World Health Organisation collaborating centre for flu research in Melbourne, said the bug appears more prone than other types of flu to developing drug resistance, The Australian reported.
With swine flu, this has not happened and the virus remains fit enough to spread to others, Hurt said.
Research on patients in Newcastle, New South Wales in 2011 found just one person in the area had used Tamiflu but the resistant form of the virus spread to 20 per cent of all those who developed swine flu in that region, News Limited Network reported.
The only way to combat the growth of drug resistant strain of the virus is to save medicines for the most needy cases, he said.
Swine flu has not yet developed resistance to Relenza, an inhaled form of anti-viral treatment.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
